Duration of treatment may be related to improvement as metformin improves AN and IR if given for 6 months or more [Figure 7a and b].[23] Metformin reduces glucose production by increasing peripheral insulin responsiveness, reduces hyperinsulinemia, body weight and fat mass and improves insulin sensitivity.[30,32,33] The combined use of metformin and TZDs which increase sensitivity to insulin in peripheral muscles, also give good results.[34] The combined metformin and glimepiride (at low dose) is superior in the management of IR studied through HOMA with reduction in HOMA-IR.[35] Metformin is known to improve cardiopulmonary performance in patients with high HOMA-IR possibly by favorable effects on endothelial dysfunction.[18] Cosmetic treatment Because darkening of affected areas is common in AN, Alan Rosenbach considered the possibility that long-pulsed alexandrite laser, which was designed to target melanin in hair could improve this condition
In a phase 2 clinical trial among Chinese patients, mazdutide reduced HbA1c by 1.41% to 1.67% in a dose dependent manner compared to +0.03% for placebo
The choice depends on individual health goals and needs
Cascio, C., Deidda, I., Russo, D
PMID: 1134886 Cairney DG, Beckwith HK, Al-Hourani K, Eddleston M, Bateman DN, Dear JW
HPLC Analysis High-Performance Liquid Chromatography (HPLC) is used to verify the purity of BPC-157
